Back
Sonoma Pharmaceuticals, Inc. Vs. Bowman Consulting Group Ltd. Industry Stock Comparison
Sell
21
SNOA
Sonoma Pharmaceuticals, Inc.
Last Price:
$2.32
Seasonality Move:
6.9%
Sell
44
BWMN
Bowman Consulting Group Ltd.
Last Price:
$29.63
Seasonality Move:
1.39%
Sell
21
Sonoma Pharmaceuticals, Inc. (SNOA)
is a Sell
Is Sonoma Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Sonoma Pharmaceuticals, Inc. [SNOA] share price is $2.37. The Score for SNOA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
SNOA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Bowman Consulting Group Ltd. (BWMN)
is a Sell
Is Bowman Consulting Group Ltd. a Buy, Sell or Hold?
-
The current Bowman Consulting Group Ltd. [BWMN] share price is $29.65. The Score for BWMN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BWMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNOA Stock Price Chart
What is Sonoma Pharmaceuticals, Inc.'s stock price today?
-
The Sonoma Pharmaceuticals, Inc. share price today is $2.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNOA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BWMN Stock Price Chart
What is Bowman Consulting Group Ltd.'s stock price today?
-
The Bowman Consulting Group Ltd. share price today is $29.65The current trend is relatively stagnant and BWMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
SNOA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 45.79 | Sell |
| Chaikin Money Flow: | 8005 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.23 - 2.67) | Sell |
| Bollinger Bands (100): | (2.65 - 3.61) | Sell |
BWMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.73 | Sell |
| Relative Strength Index (14 RSI): | 49.61 | Sell |
| Chaikin Money Flow: | 51978 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.4 - 31.18) | Buy |
| Bollinger Bands (100): | (30.57 - 35.89) | Sell |
SNOA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.23 | Buy |
| 20-day SMA: | 2.37 | Buy |
| 50-day SMA: | 2.75 | Sell |
| 200-day SMA: | 3.49 | Sell |
| 8-day EMA: | 2.17 | Buy |
| 20-day EMA: | 1.6 | Buy |
| 50-day EMA: | 0.88 | Buy |
| 200-day EMA: | 0.26 | Buy |
BWMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.98 | Buy |
| 20-day SMA: | 28.55 | Buy |
| 50-day SMA: | 31.74 | Sell |
| 200-day SMA: | 35.62 | Sell |
| 8-day EMA: | 28.94 | Buy |
| 20-day EMA: | 29.27 | Buy |
| 50-day EMA: | 31.11 | Sell |
| 200-day EMA: | 33.16 | Sell |
Sonoma Pharmaceuticals, Inc. Earnings Growth & SNOA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.05 per share.
Bowman Consulting Group Ltd. Earnings Growth & BWMN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.09 per share, and an increase next year of $0.56 per share.
Sonoma Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bowman Consulting Group Ltd. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||